IL160607A0 - Use of c2-substituted indan-1-one systems for preparing medicaments for the prophylaxis or treatment of obesity - Google Patents

Use of c2-substituted indan-1-one systems for preparing medicaments for the prophylaxis or treatment of obesity

Info

Publication number
IL160607A0
IL160607A0 IL16060702A IL16060702A IL160607A0 IL 160607 A0 IL160607 A0 IL 160607A0 IL 16060702 A IL16060702 A IL 16060702A IL 16060702 A IL16060702 A IL 16060702A IL 160607 A0 IL160607 A0 IL 160607A0
Authority
IL
Israel
Prior art keywords
prophylaxis
obesity
systems
treatment
preparing medicaments
Prior art date
Application number
IL16060702A
Other languages
English (en)
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Publication of IL160607A0 publication Critical patent/IL160607A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2264—Obesity-gene products, e.g. leptin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/10—Sulfides; Sulfoxides; Sulfones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Genetics & Genomics (AREA)
  • Child & Adolescent Psychology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IL16060702A 2001-08-31 2002-08-17 Use of c2-substituted indan-1-one systems for preparing medicaments for the prophylaxis or treatment of obesity IL160607A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10142668A DE10142668A1 (de) 2001-08-31 2001-08-31 Verwendung von C2-substituierten Indan-1-on-Systemen zur Herstellung von Medikamenten zur Prophylaxe oder Behandlung von Obesitas
PCT/EP2002/009208 WO2003020256A1 (de) 2001-08-31 2002-08-17 Verwendung von c2-substituierten indan-1-on-systemen zur herstellung von medikamenten zur prophylaxe oder behandlung von obesitas

Publications (1)

Publication Number Publication Date
IL160607A0 true IL160607A0 (en) 2004-07-25

Family

ID=7697238

Family Applications (2)

Application Number Title Priority Date Filing Date
IL16060702A IL160607A0 (en) 2001-08-31 2002-08-17 Use of c2-substituted indan-1-one systems for preparing medicaments for the prophylaxis or treatment of obesity
IL160607A IL160607A (en) 2001-08-31 2004-02-26 Use of c2-substituted indan-1-one systems for preparing medicaments for reduction of weight and for the prophylaxis or treatment of obesity

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL160607A IL160607A (en) 2001-08-31 2004-02-26 Use of c2-substituted indan-1-one systems for preparing medicaments for reduction of weight and for the prophylaxis or treatment of obesity

Country Status (10)

Country Link
US (1) US6946492B2 (sr)
EP (1) EP1424999A1 (sr)
JP (1) JP4342306B2 (sr)
AU (1) AU2002336985B2 (sr)
CA (1) CA2458555A1 (sr)
DE (1) DE10142668A1 (sr)
IL (2) IL160607A0 (sr)
MX (1) MXPA04001853A (sr)
PE (1) PE20030336A1 (sr)
WO (1) WO2003020256A1 (sr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ594236A (en) * 2009-01-26 2014-08-29 Univ Taipei Medical Use of pterosin compounds for treating diabetes and obesity
CN103333144B (zh) * 2013-06-17 2014-12-10 温州大学 一种2-硫基-3-卤代苯并呋喃化合物及其合成方法和用途

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0009554B1 (de) * 1978-07-27 1983-04-27 Schering Aktiengesellschaft Indanyl-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Präparate
RU2073673C1 (ru) * 1987-10-19 1997-02-20 Пфайзер Инк. Рацемические и оптические активные производные тетралина и 7-гидрокситетралина
ATE260241T1 (de) * 1995-12-06 2004-03-15 Venantius Ltd Indanverbindungen mit relaxierender wirkung auf die glatten muskeln und/oder mit mastzellen stabilisiernder und/oder entzuendungshemmender wirkung
CA2241567A1 (en) 1996-01-17 1997-07-24 Novo Nordisk A/S Fused 1,2,4-thiadiazine and fused 1,4-thiazine derivatives, their preparation and use
CA2468374C (en) 1996-08-30 2010-12-21 Novo-Nordisk A/S Glp-1 derivatives
ES2199366T3 (es) 1996-12-31 2004-02-16 Dr. Reddy's Laboratories Ltd. Compuestos heterociclicos, procedimiento para su preparacion y composiciones farmaceuticas que los contienen y su uso en el tratamiento de diabetes y enfermedades relacionadas.
HUP0003999A3 (en) 1997-07-16 2003-03-28 Novo Nordisk As Fused 1,2,4-thiadiazine derivatives, their preparation, their use and pharmaceutical compositions containing them
IL144765A0 (en) * 1999-03-01 2002-06-30 Pfizer Prod Inc Oxamic acids and derivatives as thyroid receptor ligands
FR2796070B1 (fr) * 1999-07-06 2003-02-21 Lipha Derives de benzodiazepines utilisables dans le traitement de dyslipidemies, de l'atherosclerose et du diabete, compositions pharmaceutiques les contenant et procedes de preparation
EP1078632A1 (en) 1999-08-16 2001-02-28 Sanofi-Synthelabo Use of monoamine oxydase inhibitors for the manufacture of drugs intended for the treatment of obesity

Also Published As

Publication number Publication date
IL160607A (en) 2011-03-31
AU2002336985B2 (en) 2006-11-16
MXPA04001853A (es) 2004-06-15
CA2458555A1 (en) 2003-03-13
US20030134882A1 (en) 2003-07-17
US6946492B2 (en) 2005-09-20
PE20030336A1 (es) 2003-05-19
WO2003020256A1 (de) 2003-03-13
JP4342306B2 (ja) 2009-10-14
JP2005503396A (ja) 2005-02-03
EP1424999A1 (de) 2004-06-09
DE10142668A1 (de) 2003-03-20

Similar Documents

Publication Publication Date Title
IL159347A0 (en) Arylamines for the treatment of conditions associated with gsk-3
HUP0600332A2 (en) Aerosolized decongestants for the treatment of sinusitis
HUP0401514A3 (en) Pharmaceutical compositions for the treatment of asthma
AU2003299791A1 (en) Substituted 3,5-dihydro-4h-imidazol-4-ones for the treatment of obesity
EP1534074A4 (en) POLYTHERAPY FOR THE TREATMENT OF OBESITY
IL159344A0 (en) Quinuclidines-substituted-multicyclic-heteroaryls for the treatment of disease
AU2002360251A8 (en) Medical devices comprising nanocomposites
IL196301A0 (en) Medicament for the treatment of hapatitis c
IL160524A0 (en) Imidazole-4-carboxamide derivatives, preparation and use thereof for treatment of obesity
AU2002310325A1 (en) Use of ozone for the prevention of infection caused by medical devices
IL161041A0 (en) Mch antagonists for the treatment of obesity
EP1384493A4 (en) IRRADIATOR
EP1390029A4 (en) PHENYLINDOLES FOR THE TREATMENT OF HIV INFECTION
HK1061212A1 (en) Pyranoindazoles and their use for the treatment ofglaucoma
GB0524780D0 (en) Device for the prevention or treatment of ulcers
IL178903A0 (en) Medicaments containing n-sulfamoyl-n'-arylpiperazines for the prophylaxis or treatment of obesity and related conditions
AU2003263760A1 (en) Methods for the treatment or prevention of obesity
IL157145A0 (en) Use of dc23 antagonists for the treatment of neoplastic disorders
IL160600A0 (en) Use of polysubstituted indan-1-ol systems for the preparation of medicaments for the prophylaxis or treatment of obesity
AU2002364171A8 (en) Materials and methods for the treatment or prevention of obesity
HK1062810A1 (en) Use of il-18 inhibitors for the manufacture of medicaments for treatment and/or prevention of heartdisease
AU2002333447A1 (en) Use of polysubstituted indan-1-ol systems for producing drugs in the prophylaxis or treatment of obesity
AU2002236781A1 (en) Treatment for snoring
IL160607A0 (en) Use of c2-substituted indan-1-one systems for preparing medicaments for the prophylaxis or treatment of obesity
AU2002336984A1 (en) Use of C2-substituted Indane-1-ol systems for producing medicaments for the prophylaxis or treatment of obesity

Legal Events

Date Code Title Description
FF Patent granted